Rytlewski, J.D.; Scalora, N.; Garcia, K.; Tanas, M.; Toor, F.; Miller, B.; Allen, B.; Milhem, M.; Monga, V.
Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas. Cancers 2021, 13, 675.
https://doi.org/10.3390/cancers13040675
AMA Style
Rytlewski JD, Scalora N, Garcia K, Tanas M, Toor F, Miller B, Allen B, Milhem M, Monga V.
Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas. Cancers. 2021; 13(4):675.
https://doi.org/10.3390/cancers13040675
Chicago/Turabian Style
Rytlewski, Jeffrey D., Nicholas Scalora, Keith Garcia, Munir Tanas, Fatima Toor, Benjamin Miller, Bryan Allen, Mohammed Milhem, and Varun Monga.
2021. "Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas" Cancers 13, no. 4: 675.
https://doi.org/10.3390/cancers13040675
APA Style
Rytlewski, J. D., Scalora, N., Garcia, K., Tanas, M., Toor, F., Miller, B., Allen, B., Milhem, M., & Monga, V.
(2021). Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas. Cancers, 13(4), 675.
https://doi.org/10.3390/cancers13040675